Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers.
暂无分享,去创建一个
N. Andrews | K. Brown | K. Ayres | S. L. McDonald | A. Gershon | J. Breuer | S. Steinberg | P. Maple | F. Scott | M. A. al Bassam
[1] J. Gray,et al. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection. , 2009, Journal of virological methods.
[2] J. Gray,et al. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals. , 2009, Journal of virological methods.
[3] K. Edwards,et al. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. , 2008, The Journal of infectious diseases.
[4] J. Gray,et al. Performance of a Time-Resolved Fluorescence Immunoassay for Measuring Varicella-Zoster Virus Immunoglobulin G Levels in Adults and Comparison with Commercial Enzyme Immunoassays and Merck Glycoprotein Enzyme Immunoassay , 2006, Clinical and Vaccine Immunology.
[5] J. Heyse,et al. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection , 2002, The Pediatric infectious disease journal.
[6] L. Saiman,et al. Persistence of immunity to live attenuated varicella vaccine in healthy adults. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] J. Seward. UPDATE ON VARICELLA , 2001, The Pediatric infectious disease journal.
[8] L. Saiman,et al. Persistence of Immunity to Varicella-Zoster Virus After Vaccination of Healthcare Workers , 2001, Infection Control & Hospital Epidemiology.
[9] P. LaRussa,et al. Detection of antibodies to varicella-zoster virus using a latex agglutination assay. , 1994, Clinical and diagnostic virology.
[10] W. Miller,et al. Sensitive enzyme‐linked immunosorbent assay for antibody to varicella‐zoster virus using purified VZV glycoprotein antigen , 1990, Journal of medical virology.
[11] P. LaRussa,et al. Immunization of healthy adults with live attenuated varicella vaccine. , 1988, The Journal of infectious diseases.
[12] P. Gerber,et al. Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus , 1982, Journal of clinical microbiology.
[13] C. Grose,et al. Complement-enhanced neutralizing antibody response to varicella-zoster virus. , 1979, The Journal of infectious diseases.
[14] A. Gershon,et al. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. , 1974, The Journal of infectious diseases.
[15] J. Gray,et al. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.